Market Cap 148.65B
Revenue (ttm) 22.60B
Net Income (ttm) 2.99B
EPS (ttm) N/A
PE Ratio 31.51
Forward PE 29.56
Profit Margin 13.25%
Debt to Equity Ratio 0.80
Volume 1,432,000
Avg Vol 1,242,112
Day's Range N/A - N/A
Shares Out 381.69M
Stochastic %K 40%
Beta 0.91
Analysts Strong Sell
Price Target $432.73

Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the t...

Industry: Medical Devices
Sector: Healthcare
Phone: (269) 385-2600
Fax: (269) 385-1062
Address:
1941 Stryker Way, Portage, United States
Quantumup
Quantumup Jul. 15 at 1:07 PM
BofA reit'd $PRCT Buy-$84 after Center of Medicare and Medicaid Services (CMS) released its proposed physician fee schedule (PFS) for 2026 which includes what a doctor will get paid to perform PRCT's Aquablation under its new Category I CPT code. $BSX $ISRG $SYK $MDT GEHC BofA said in its note:
0 · Reply
Snakewatching
Snakewatching Jul. 15 at 11:24 AM
$MBOT The society of robotic surgery annual meeting starts tomorrow in France... This will be some great exposure for Microbot Medical in the European theater.... If you go to the industry partners page, you will see a ton of robotic surgery companies like $SYK and $ISRG with $JNJ ... Should be some very interesting times in the next week.. srobotics.org
0 · Reply
cheddar__
cheddar__ Jul. 10 at 8:30 PM
$EW $SYK $BSX $MDT $ABT Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older patients https://bbtw.cheddar.com/p/medtech-stocks-defy-spending-cuts-and-soar
0 · Reply
TheTradingAnalyst
TheTradingAnalyst Jul. 10 at 6:59 AM
$SYK with a bullish setup... $SPX $SPY $QQQ Nice setup. Great opportunity to participate in the next up leg. Good luck. Real-time alerts at http://thetradinganalyst.com
0 · Reply
Quantumup
Quantumup Jul. 9 at 1:08 PM
Stephens🏁 $PRCT Overweight-$70 and said "Premium Price, Premium Potential: A Surgical Disruptor in BPH; Initiating OW-Vol./$70 PT" $BSX $ISRG $SYK $MDT #BPH #PCa Stephens said in its note that it expects $PRCT to post robust growth and margin expansion as adoption of Aquablation continues to expand. Stephens added: ● Aquablation is disrupting the benign prostatic hyperplasia (BPH) market by taking share from existing procedures and capturing patients who historically delayed or avoided surgery. ● Believes expanding into prostate cancer has the potential to drive meaningful growth longer-term.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 8:18 AM
$SYK Brilliant piece that captures SYK's situation perfectly. So if you want to update your understanding of SYK or get to know SYK better, this is essential reading. https://beyondspx.com/article/stryker-sustaining-high-growth-through-innovation-and-strategic-portfolio-evolution-nyse-syk
0 · Reply
SilverEagle
SilverEagle Jul. 8 at 11:59 AM
$SYK watching over 400
0 · Reply
rich54
rich54 Jul. 3 at 2:00 PM
$CRMD Cormedix investors shd pay attention to $MBOT MBOT is CRMD 1-2 years ago. Approval almost there. Got delayed a bit. Both will likely be bought out by $SYK or similar at some point
1 · Reply
bwangst
bwangst Jul. 3 at 8:29 AM
$MBOT $SYK Could you simply introduce what LIBERTY can do?
0 · Reply
Marcusjoback
Marcusjoback Jul. 3 at 4:57 AM
Once LIBERTY receives FDA approval, $MBOT will bring the technology and $SYK will bring the existing Sales channel and distribution in their strategic collaboration, so the only question is will Stryker eventually acquire them for more or less than $10 billion? I’m going with slightly over ✌️
1 · Reply
Latest News on SYK
The Big 3: NXT, ANET, SYK

Jun 26, 2025, 1:01 PM EDT - 19 days ago

The Big 3: NXT, ANET, SYK

ANET NXT


Stryker receives FDA clearance for Incompass Total Ankle System

Jun 25, 2025, 8:15 AM EDT - 20 days ago

Stryker receives FDA clearance for Incompass Total Ankle System


Stryker declares an $0.84 per share quarterly dividend

May 8, 2025, 8:00 AM EDT - 2 months ago

Stryker declares an $0.84 per share quarterly dividend


Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:28 PM EDT - 2 months ago

Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript


Stryker reports first quarter 2025 operating results

May 1, 2025, 4:05 PM EDT - 2 months ago

Stryker reports first quarter 2025 operating results


Stryker completes sale of U.S. spinal implants business

Apr 1, 2025, 4:05 PM EDT - 3 months ago

Stryker completes sale of U.S. spinal implants business


Stryker announces Annual Meeting of Shareholders

Mar 25, 2025, 4:15 PM EDT - 4 months ago

Stryker announces Annual Meeting of Shareholders


The Big 3: MMM, PM, SYK

Mar 18, 2025, 1:01 PM EDT - 4 months ago

The Big 3: MMM, PM, SYK

MMM PM


Stryker launches Steri-Shield 8 personal protection system

Mar 4, 2025, 8:07 AM EST - 4 months ago

Stryker launches Steri-Shield 8 personal protection system


Stryker launches Sync Badge

Mar 3, 2025, 8:07 AM EST - 4 months ago

Stryker launches Sync Badge


The Big 3: FTNT, NXT, SYK

Feb 20, 2025, 12:14 PM EST - 5 months ago

The Big 3: FTNT, NXT, SYK

FTNT NXT


Kadant Set to Join S&P SmallCap 600

Feb 13, 2025, 5:54 PM EST - 5 months ago

Kadant Set to Join S&P SmallCap 600

KAI


Sales Growth, Strategic Acquisitions Drive Stryker Higher

Jan 31, 2025, 4:34 PM EST - 5 months ago

Sales Growth, Strategic Acquisitions Drive Stryker Higher


Overlooked Stock: SYK

Jan 28, 2025, 4:45 PM EST - 6 months ago

Overlooked Stock: SYK


Stryker reports 2024 operating results and 2025 outlook

Jan 28, 2025, 4:05 PM EST - 6 months ago

Stryker reports 2024 operating results and 2025 outlook


Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

Jan 6, 2025, 5:19 PM EST - 6 months ago

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion


Stryker Bringing in Big Money

Nov 20, 2024, 3:21 AM EST - 8 months ago

Stryker Bringing in Big Money


Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 8:37 PM EDT - 9 months ago

Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript


Quantumup
Quantumup Jul. 15 at 1:07 PM
BofA reit'd $PRCT Buy-$84 after Center of Medicare and Medicaid Services (CMS) released its proposed physician fee schedule (PFS) for 2026 which includes what a doctor will get paid to perform PRCT's Aquablation under its new Category I CPT code. $BSX $ISRG $SYK $MDT GEHC BofA said in its note:
0 · Reply
Snakewatching
Snakewatching Jul. 15 at 11:24 AM
$MBOT The society of robotic surgery annual meeting starts tomorrow in France... This will be some great exposure for Microbot Medical in the European theater.... If you go to the industry partners page, you will see a ton of robotic surgery companies like $SYK and $ISRG with $JNJ ... Should be some very interesting times in the next week.. srobotics.org
0 · Reply
cheddar__
cheddar__ Jul. 10 at 8:30 PM
$EW $SYK $BSX $MDT $ABT Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older patients https://bbtw.cheddar.com/p/medtech-stocks-defy-spending-cuts-and-soar
0 · Reply
TheTradingAnalyst
TheTradingAnalyst Jul. 10 at 6:59 AM
$SYK with a bullish setup... $SPX $SPY $QQQ Nice setup. Great opportunity to participate in the next up leg. Good luck. Real-time alerts at http://thetradinganalyst.com
0 · Reply
Quantumup
Quantumup Jul. 9 at 1:08 PM
Stephens🏁 $PRCT Overweight-$70 and said "Premium Price, Premium Potential: A Surgical Disruptor in BPH; Initiating OW-Vol./$70 PT" $BSX $ISRG $SYK $MDT #BPH #PCa Stephens said in its note that it expects $PRCT to post robust growth and margin expansion as adoption of Aquablation continues to expand. Stephens added: ● Aquablation is disrupting the benign prostatic hyperplasia (BPH) market by taking share from existing procedures and capturing patients who historically delayed or avoided surgery. ● Believes expanding into prostate cancer has the potential to drive meaningful growth longer-term.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 8:18 AM
$SYK Brilliant piece that captures SYK's situation perfectly. So if you want to update your understanding of SYK or get to know SYK better, this is essential reading. https://beyondspx.com/article/stryker-sustaining-high-growth-through-innovation-and-strategic-portfolio-evolution-nyse-syk
0 · Reply
SilverEagle
SilverEagle Jul. 8 at 11:59 AM
$SYK watching over 400
0 · Reply
rich54
rich54 Jul. 3 at 2:00 PM
$CRMD Cormedix investors shd pay attention to $MBOT MBOT is CRMD 1-2 years ago. Approval almost there. Got delayed a bit. Both will likely be bought out by $SYK or similar at some point
1 · Reply
bwangst
bwangst Jul. 3 at 8:29 AM
$MBOT $SYK Could you simply introduce what LIBERTY can do?
0 · Reply
Marcusjoback
Marcusjoback Jul. 3 at 4:57 AM
Once LIBERTY receives FDA approval, $MBOT will bring the technology and $SYK will bring the existing Sales channel and distribution in their strategic collaboration, so the only question is will Stryker eventually acquire them for more or less than $10 billion? I’m going with slightly over ✌️
1 · Reply
ZacksResearch
ZacksResearch Jun. 30 at 12:57 PM
$SYK expands its footprint with FDA clearance for InCompass Total Ankle System! 🚀 🎯 Targets severe ankle arthritis with surgeon-informed design 🏥 Strengthens position in fast-growing foot & ankle market See why this could boost SYK’s orthopaedics segment top-line growth 👉 https://www.zacks.com/commentary/2557481/syk-boosts-foot-ankle-portfolio-with-fda-cleared-total-ankle-system?cid=sm-stocktwits-2-2557481-body-394&ADID=SYND_STOCKTWITS_TWEET_2_2557481_BODY_394
0 · Reply
roejohn
roejohn Jun. 26 at 2:15 PM
$SYK Unbelievable company and I bet the majority of your patients are diabetic . With your distribution to surgeons , I think SYK should look at SENSEONICS , SENS … The implantable CGM THAT really saves lives and gives diabetics a lifestyle .. Eversense 365 that is FDA and Medicare approved . Your medical doctors and your expertise in educating would be a great match .. plus this product will be approved in Europe soon . This product is Godsend . Took years to develop and is helping some but not enough patients or physicians are aware !
0 · Reply
SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
StockAutoPro
StockAutoPro Jun. 16 at 11:34 PM
$SYK: Trading at $377.12, stable. Buy near $375, target $380 with medical devices demand steady.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 11 at 11:36 AM
Projected 90-day price trend outlook for $SYK, based on historical performance patterns and recent earnings-related momentum. #stocks #trading #investing
0 · Reply
zoey1970
zoey1970 Jun. 10 at 9:43 AM
$INTC Whisker Wisdom: How Rat-Inspired AI Redefines Robotics In the perilous realm of search and rescue, where every second counts amidst crumbling structures or toxic fumes, human responders face daunting risks. Similarly, monitoring hazardous environments, be it tracking pollution plumes or assessing volatile chemical leaks demands precision in unforgiving conditions. Traditional methods, reliant on human courage or static sensor networks, often fall short under these pressures. Enter robotics, m A new study, Self-powered artificial vibrissal system with anemotaxis behavior by Meng Qi and colleagues, published in Science Advances (4 June 2025), unearths a bioinspired solution that harnesses rat-like sensory prowess to redefine robotic capabilities. Read more here if interested... https://neuromorphiccore.ai/whisker-wisdom-how-rat-inspired-ai-redefines-robotics/ #AI, #Autonomous, #BioinspiredRobotics, #Neuromorphic, #Robotics, #Sensors $MCHP, $ZBRA, $ABB, $SYK,
0 · Reply
rich54
rich54 Jun. 9 at 4:19 PM
$CRMD Next CRMD is $MBOT It got a small disappointment today but it is positioned exactly like CRMD few months/quarters ago. Both could be targets of acquisition by $SYK Holding both & hoping for great future ahead
1 · Reply
Gorohanada
Gorohanada Jun. 9 at 3:14 PM
$SYK They are doing millions of knee replacements in India
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 3:40 AM
$SYK With surgical robotics, rising dividends, & expansion, Stryker is becoming a healthcare titan. Here's why SYK can be your next winning move. https://biotechhealthx.com/biotech-news/stryker-syk-is-quietly-dominating-the-medtech-industry-heres-what-investors-need-to-know/
0 · Reply
Marcusjoback
Marcusjoback May. 29 at 9:53 PM
Just look at $MBOT Massive Total Addressable Market and $ISRG $SYK & $GEHC can’t compete with our Remote LIBERTY technology patents that essentially eliminate radiation effects and acquiring us for our IP won’t be cheap! ✌️
0 · Reply
roejohn
roejohn May. 29 at 6:17 PM
$SYK $SENS , has an approved implantable CGM , FDA and Medicare . The combination of SYK and SENS makes sense . SENS is a necessity ! EVERSENSE 365
0 · Reply
Ro_Patel
Ro_Patel May. 26 at 6:04 PM
Drawdowns & recoveries of US stocks w/ highest & lowest total shareholder returns from 1985 to 2024 $BRO $SYK $EXPD $SHW $AMGN Note: Many of the big tech co.s today, such as Tesla and even Amazon & Nvidia, had their IPOs much later than 1985
1 · Reply